Home » Newsletters

Newsletters

BioWorld

BioWorld MedTech

BioWorld Asia

BioWorld Science

Today's news in brief
BioWorld
BioWorld briefs for Nov. 20, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 20, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
J&J’s Ottava robotic system approved for US pivotal trial
BioWorld MedTech
Johnson & Johnson received U.S. FDA investigational device exemption to begin the pivotal clinical trial for the Ottava robotic surgical system. If the trial goes...
GLP-1s push into MASH as semaglutide 2.4 mg hits endpoints
BioWorld
Positive findings from a phase III trial of semaglutide in metabolic dysfunction-associated steatohepatitis (MASH) is moving Novo Nordisk A/S to expand the...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.